Tandem Diabetes Care, Inc.
Meridian owns Tandem Diabetes Care for its differentiated insulin-pump technology, expanding installed base, and recurring supply revenue that grows with the user base. Shares…
TNDM
2 published ideas on Tandem Diabetes Care, Inc. across 2 funds — 2 long and 0 short.
Each stock pitch below comes from a fund manager's own investor letter, not a 13F filing, so it carries the reasoning behind the portfolio position on Tandem Diabetes Care: the full investment thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.
Meridian owns Tandem Diabetes Care for its differentiated insulin-pump technology, expanding installed base, and recurring supply revenue that grows with the user base. Shares…
Tandem is the number three player in the global automated insulin-pump market and is changing its commercial model toward pharmacy pay-as-you-go. A new tubeless product is…